Oral gel capsule formulation of 1,2,4-benzotriazine oxides

Details Oral gel capsule formulation of 1,2,4-benzotriazine oxides Oral gel capsule formulation of 1,2,4-benzotriazine oxides

A - Human Necessities

61

K

A61K 31/535 (2006.01) A61K 9/48 (2006.01) A61K 31/53 (2006.01)

Patent

CA 2231545

Disclosed are anticancer tumor soft gelatin capsules comprising a 1,2,4- benzotriazine oxide and an oily excipient selected from the group consisting of soybean oil and fractionated coconut oil.

La présente invention concerne des capsules de gélatine molle destinées au traitement de tumeurs cancéreuses, et contenant un oxyde de 1, 2, 4-benzotriazine et un excipient huileux choisi dans le groupe constitué par l'huile de soja et l'huile de noix de coco fractionnée.

Affiliated with

Also associated with

Rating

Oral gel capsule formulation of 1,2,4-benzotriazine oxides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral gel capsule formulation of 1,2,4-benzotriazine oxides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral gel capsule formulation of 1,2,4-benzotriazine oxides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1741680